SEC Form 4 · accession 0001078782-16-002691
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Cameron John Reynolds
Officer — President and CEO · Director
Period of report
Apr 20, 2016
Accepted (ET)
Apr 22, 2016 · 10:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2016 | X | 1,172 | $2.60 | A | 1,103,844 | D | |
| Common Stock | Apr 20, 2016 | X | 1,429 | $2.60 | A | 28,287 | I | By Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy) | $2.60 | Apr 20, 2016 | X | 1,172 | D | May 11, 2012 | May 10, 2016 | Common Stock | 1,172 | 0 | D |
| Warrant (Right to Buy) | $2.60 | Apr 20, 2016 | X | 1,429 | D | May 11, 2012 | May 10, 2016 | Common Stock | 1,429 | 0 | I |